BackAbri SPAC I Overview

Abri SPAC I Total Liabilities

Track Abri SPAC I's total liabilities ($15B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$15.24B
↑ 180776.75% YoYΔ $15.23B vs prior year quarter

Peer average

Loading

Abri SPAC I Total Liabilities History

Loading

Abri SPAC I vs. peers: Total Liabilities Comparison

Loading

Abri SPAC I Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Abri SPAC I (ASPA) FAQ

As of the most recent data (September 2024), ASPA shows a total liabilities of $15B. That compares with $8.4M in the prior-year period — up 180776.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASPA's total liabilities is now $15B (was $8.4M) — a 180776.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Abri SPAC I is outperforming or lagging.

Tracking ASPA's total liabilities over time shows whether Abri SPAC I is scaling, shrinking, or reshaping that part of the business. The current reading is $15B That compares with $8.4M in the prior-year period — up 180776.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Abri SPAC I's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $15B) with ownership activity and broader fundamentals.